Workup
Laboratory Studies
- Preoperative laboratory studies include a complete blood cell count, electrolyte evaluation, and bleeding and coagulation parameters.
- Masses located in or around the sella turcica merit serum endocrine studies.
- Paragangliomas: Catecholamine secretion can be diagnosed with urine or serum studies.
Imaging Studies
General imaging studies for assessment of skull base tumors include the following:
- CT scan of the brain with thin cuts and sagittal and coronal reconstructions can reveal abnormalities of the bone (eg, erosion, hyperostosis) and calcification in the tumor.
- Brain MRI with and without gadolinium is the best study to evaluate soft tissue masses and structures.
- Cerebral angiography is beneficial if the tumor encroaches on the carotid or other major intracranial arteries or a major venous sinus. It is used to assess whether arteries and venous sinuses are patent. In the case of meningioma and other vascular tumors, angiographic embolization of appropriate feeding vessels can decrease blood loss during operative resection and contribute to the ease of tumor removal.
- MR arteriography and venography may also be used to assess the patency of arterial and venous structures.
- If a metastatic tumor has an unknown primary source, a systemic workup should be performed. Imaging tests include posteroanterior and lateral chest radiography; contrast-enhanced CT scan of the chest, abdomen, and pelvis; and a bone scan.
- Osteoma: Diagnosis is based on the radiographic appearance. The most sensitive test is CT scanning, in which the lesion appears as a circumscribed homogeneous bony density (see Image 1).
- Chondroma: Radiographically, chondromas are best characterized by CT scanning; these tumors appear as lytic lesions with sharp margins and erosion of surrounding bone. Stippled calcification within the lesion helps distinguish it from a metastasis or chordoma.
- Hemangioma: Skull radiographs may demonstrate a circular lucency with trabeculations. CT scanning demonstrates a nonenhancing hypodense lesion. Flow voids may be visualized on MRI.
- Dermoid and epidermoid tumors of the skull: Radiographs demonstrate rounded or ovoid lytic lesions with sharp sclerotic margins. On CT scans, these lesions are nonenhancing and hypodense and involve all 3 bone layers. MRI demonstrates a low-intensity lesion on T1 and a high-intensity lesion on T2.
- Paragangliomas: MRI and magnetic resonance (MR) angiography best characterize paragangliomas because these modalities usually reveal their extensive vascularity, meriting preoperative embolization in many cases (see Images 3 and 4).
- Metastasis to the skull base: MRI scans can reveal even small skull base metastases. Almost all tumors can be visualized, especially if they lie within the cavernous sinus.
- Direct extension of malignant tumors to the skull base: Imaging demonstrates erosion of the skull base and the presence of a soft tissue mass.
- Osteogenic sarcoma and fibrous sarcoma: Fibrous sarcoma is a soft tissue tumor that arises from bone, periosteum, scalp, or dura. It is often accompanied by bony destruction, showing a regular but discrete lytic radiographic picture.
- Vestibular schwannoma: MRI is the best modality for the diagnosis of a vestibular schwannoma. The tumor enhances vigorously, and its origin in the internal auditory canal distinguishes it from a meningioma. CT scanning with contrast demonstrates most tumors larger than 1.5 cm.
- Trigeminal schwannoma: Diagnosis is best established with MRI.
- Meningioma
- Imaging of skull base meningiomas includes CT scanning, MRI, and sometimes angiography, which can be obtained in conjunction with embolization of feeding arteries. On nonenhanced CT scans, the tumor is isodense or slightly hyperdense compared with the brain. The mass is generally smooth and sometimes lobulated, and calcifications are often appreciated. Contrast enhancement is strong and homogeneous; margins are distinct, and the tumor’s dural base can usually be appreciated (see Image 15). Hyperostosis of the underlying bone is common and can be appreciated radiographically. Hyperostosis of the immediately adjacent bone is seen in 25% of patients (see Images 13 and 14).
- On MRI, the tumor is isointense (65%) or hypointense (35%) when compared with normal brain on both T1-weighted and T2-weighted imaging. Intense and homogeneous gadolinium enhancement is visible, and the dural tail is often evident. MRI is the best modality to define the relationship between the tumor and surrounding structures.
- Atypical radiographic features such as cysts, hemorrhage, and central necrosis, which can mimic features of glioma, are visible in about 15% of meningiomas. Malignant meningiomas commonly demonstrate bone destruction, necrosis, irregular enhancement, and extensive edema. MRI demonstrates the rare cases of direct brain invasion by tumor. The differential diagnosis of radiographically atypical meningiomas includes dural metastasis, other primary meningeal tumors (eg, sarcoma), granuloma, or aneurysm. Metastases are commonly associated with abundant surrounding edema and bone destruction; in contrast, hyperostosis and moderate edema suggest meningioma.
- On angiograms, skull base meningiomas are hypervascular, generally with feeding vessels from the external carotid artery. Encased or compromised arteries and venous sinus involvement can be assessed using MR or CT angiography, which greatly contributes to operative planning. Catheter angiography is reserved for cases in which balloon test occlusion (BTO) or arterial embolization is planned.
- Hemangiopericytoma: Gadolinium-enhanced MRI best characterizes these lesions (see Image 16). CT scanning may help differentiate hemangiopericytoma from a meningioma by demonstrating local osteolysis, rather than the hyperostosis that may be seen with meningioma. Angiography can demonstrate the tumor’s vascularity, and embolization can be a helpful adjunct prior to surgical intervention.
- Tumors of the posterior cranial fossa: MRI usually differentiates a meningioma from a vestibular schwannoma because the latter begins within the internal auditory canal.
Other Tests
- In the appropriate clinical setting, additional tests are used to formally evaluate cranial nerve function. Tests may include a formal visual field evaluation, audiography, or swallowing study.
- Vestibular schwannoma: Hearing function can be evaluated using brainstem auditory evoked potentials, caloric stimulation with electronystagmography, and audiometry.
- Tumors of the posterior cranial fossa: Abnormalities found on electronystagmography, audiography, and brainstem auditory evoked potentials testing are less common than with vestibular schwannomas, but these tests are rarely needed with current imaging techniques.
Diagnostic Procedures
Balloon test occlusion (BTO): Large vessel compromise due to tumor involvement can be documented preoperatively with angiography to allow for adequate presurgical planning. If a large vessel requires ligation during the operative approach or tumor resection, a BTO gives the surgeon an indication of whether the patient might tolerate vessel sacrifice or if a bypass procedure is required.
More on Skull Base Tumors |
| Overview: Skull Base Tumors |
Workup: Skull Base Tumors |
| Treatment: Skull Base Tumors |
| Follow-up: Skull Base Tumors |
| Multimedia: Skull Base Tumors |
| References |
| « Previous Page | Next Page » |
References
Schwartz TH, Rhiew R, Isaacson SR, Orazi A, Bruce JN. Association between intracranial plasmacytoma and multiple myeloma: clinicopathological outcome study. Neurosurgery. Nov 2001;49(5):1039-44; discussion 1044-5. [Medline].
Greenberg M. Handbook of Neurosurgery. 5th Edition. New York: Thieme; 2001:447.
Burger PC. Surgical Pathology of the Nervous System and its Coverings. 4th ed. New York: Churchill-Livingstone; 2002:p. 15.
Van Havenbergh T, Carvalho G, Tatagiba M, Plets C, Samii M. Natural history of petroclival meningiomas. Neurosurgery. Jan 2003;52(1):55-62; discussion 62-4. [Medline].
Pieper DR, LaRouere M, Jackson IT. Operative management of skull base malignancies: choosing the appropriate approach. Neurosurg Focus. May 15 2002;12(5):e6. [Medline].
Origitano TC, Petruzzelli GJ, Vandevender D, Emami B. Management of malignant tumors of the anterior and anterolateral skull base. Neurosurg Focus. May 15 2002;12(5):e7. [Medline].
McGrew BM, Jackson CG, Redtfeldt RA. Lateral skull base malignancies. Neurosurg Focus. May 15 2002;12(5):e8. [Medline].
Kryzanski JT, Annino DJ Jr, Heilman CB. Complication avoidance in the treatment of malignant tumors of the skull base. Neurosurg Focus. May 15 2002;12(5):e11. [Medline].
Pollock BE. Stereotactic radiosurgery for intracranial meningiomas: indications and results. Neurosurg Focus. May 15 2003;14(5):e4. [Medline].
Kondziolka D, Lunsford LD, Flickinger JC. Comparison of management options for patients with acoustic neuromas. Neurosurg Focus. May 15 2003;14(5):e1. [Medline].
Witt TC. Stereotactic radiosurgery for pituitary tumors. Neurosurg Focus. May 15 2003;14(5):e10. [Medline].
Osborn A.G. Diagnostic Neuroradiology. St. Louis, Mosby. 1994;1st Ed:p.550.
Cavallo LM, Messina A, Cappabianca P, Esposito F, de Divitiis E, Gardner P, et al. Endoscopic endonasal surgery of the midline skull base: anatomical study and clinical considerations. Neurosurg Focus. Jul 15 2005;19(1):E2. [Medline].
Sekhar LN, Swamy NK, Jaiswal V, Rubinstein E, Hirsch WE Jr, Wright DC. Surgical excision of meningiomas involving the clivus: preoperative and intraoperative features as predictors of postoperative functional deterioration. J Neurosurg. Dec 1994;81(6):860-8. [Medline].
Van Tuyl R, Gussack GS. Prognostic factors in craniofacial surgery. Laryngoscope. Mar 1991;101(3):240-4. [Medline].
Chang CY, O'Rourke DK, Cass SP. Update on skull base surgery. Otolaryngol Clin North Am. Jun 1996;29(3):467-501. [Medline].
D'Ambrosio AL, Bruce JN. Treatment of meningioma: an update. Curr Neurol Neurosci Rep. May 2003;3(3):206-14. [Medline].
Jackson IT. Craniofacial osteotomies to facilitate the resection of tumors of the skull base. Neurosurgery. 1996;II:1585-602.
Kokkino AJ, Abdel Aziz KM, Tew JM Jr. Honored guest presentation: contemporary treatment of skull base meningiomas. Clin Neurosurg. 2000;46:554-74. [Medline].
Levine PA, McLean WC, Cantrell RW. Esthesioneuroblastoma: the University of Virginia experience 1960-1985. Laryngoscope. Jul 1986;96(7):742-6. [Medline].
Levine PA, Scher RL, Jane JA, Persing JA, Newman SA, Miller J, et al. The craniofacial resection--eleven-year experience at the University of Virginia: problems and solutions. Otolaryngol Head Neck Surg. Dec 1989;101(6):665-9. [Medline].
Liu JK, Gottfried ON, Couldwell WT. Surgical management of posterior petrous meningiomas. Neurosurg Focus. Jun 15 2003;14(6):e7. [Medline].
Long DM. Surgical approaches to the skull base: an overview. Neurosurgery. II:1573-84.
Ragel B, Jensen RL. Pathophysiology of Meningiomas. Seminars in Neurosurgery. 2003;14 (3).
Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. Nov 1999;23(11):1370-8. [Medline].
Sampson JH, Wilkins RH. Paragangliomas of the carotid body and temporal bone. Neurosurgery. 1996;II:1559-72.
Scher RL, Richtsmeier WJ. Craniofacial resection of anterior skull base tumors. Neurosurgery. 1996;II:1603-10.
Sekhar LN, Chanda A. Neurological Surgery. In: âChordoma and Chondrosarcomaâ�. 5th ed. Elsevier, Phildelphia: 2004.
Sekhar LN, Gay E, Wright DC. Chordomas and chondrosarcomas of the cranial base. Neurosurgery. 1996;II:1529-44.
Wanebo JE, Bristol RE, Porter RR, Coons SW, Spetzler RF. Management of cranial base chondrosarcomas. Neurosurgery. Feb 2006;58(2):249-55; discussion 249-55. [Medline].
Further Reading
Keywords
skull base tumors, brain tumor, skull base surgery, skull-base tumor, skull-base surgery, brain surgery, skull-base mass, skull base mass, brain mass, meningioma, intracranial tumor, schwannoma, chondrosarcoma, chordoma, metastatic bone lesion, osteoma, en plaque tumor, en masse tumor, neurinoma, neurilemoma, acoustic neuroma, anterior cranial fossa tumor, juvenile angiofibroma, esthesioneuroblastoma, inverted papilloma, lymphomas, nasopharyngeal carcinoma, orbital glioma, orbital tumor, orbital mass, rhabdomyosarcoma, osteogenic sarcoma, ossifying fibroma, esthesioneuroblastoma, olfactory neuroblastoma, nasopharyngeal carcinoma, middle cranial base tumor, pituitary adenoma, craniopharyngioma, temporal bone tumor, cholesteatoma, enchondroma, posterior cranial fossa tumor, epidermoid tumor, dermoid tumor, chondroma, glomus tumor, paraganglioma
Workup: Skull Base Tumors